© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Voriconazole stands out as a synthetic antifungal agent, widely recognized for treating invasive fungal infections that stubbornly resist classic therapies. Developed to target organisms such as Aspergillus and Candida species, voriconazole has found its place as a cornerstone in both clinical and industrial applications. Specialty pharmacies handle it with care, appreciating the intricacies behind its development, its manufacturing, and the protocols for safe distribution. This compound enters as white to slightly off-white crystalline powder, signaling its purity and eligibility for pharmaceutical use. Clinics and labs trust its properties because, over years of rigorous use, its molecular consistency and action against fungal cell membranes have been well documented.
The physical profile of voriconazole captures the attention of chemists and pharmaceutical personnel alike. It features a molecular formula of C16H14F3N5O, which unpacks to a chemical structure characterized by a triazole ring—something prized for its biological activity—and a series of fluorine atoms attached to its benzene ring, increasing both efficacy and metabolic stability. With a molecular weight of 349.3 g/mol, it comfortably lands in the mid-range for oral and intravenous agents, making it practical for transport and storage. Considering its characteristics, this substance typically appears in dense crystalline or powder forms, often stored in tightly sealed containers to prevent degradation.
Specific gravity comes in close to 1.44 g/cm³, reflecting its dense crystalline structure. These seemingly small details truly matter: packing, dosing, and reconstitution in clinical settings depend on knowing how it interacts with solvents and carriers. The melting point, found near 127°C, provides a useful reference for both synthesis and stability testing. Its solubility leans towards polar organic solvents, meaning methanol and dimethyl sulfoxide are preferred over water. Recognizing and verifying these specifications guards against mishandling and enables consistent performance across batches.
In my experience coordinating between pharmaceutical suppliers and hospital pharmacies, keeping strict control over hazardous compounds always takes top priority. Voriconazole, like most azole antifungals, arrives in raw form as a powder. Breathing in or direct contact risks irritation, especially among people with respiratory issues or skin sensitivities. Proper use of gloves, protective clothing, and fume hoods keeps people safe, not only in the laboratory but during large-scale production and transfer. The HS Code frequently recognized for voriconazole and similar pharmaceutical intermediates, 2934999099, ensures customs and regulatory bodies can accurately track and classify the substance.
Storing this compound in a cool, dry setting preserves its integrity. Exposing it to humidity or excess heat can trigger slow breakdown, a costly mistake when every gram must meet strict pharmacopeia standards. Regulatory guidelines explain that safety information, detailed procedures for spills, and first aid plans remain just as important as the product label or data sheet. Although voriconazole plays a valuable role as a medication, mishandling the raw chemical highlights the thin line between therapy and toxicity in pharmaceutical work.
Voriconazole’s function stretches beyond hospitals. Raw materials arrive in large containers—sometimes as flakes, sometimes as dense powder—headed straight to compounding pharmacies or research labs. Rarely does the average consumer see these forms, yet these represent the backbone of the entire supply chain. Chemists may dissolve the powder in alcohols or sterile water to prepare concentrated solutions for studies. Engineering teams optimize blending processes, always careful to prevent dust generation, which can escalate risks in a large-scale facility. Meanwhile, stringent tracking ensures any batch can be traced from raw material to finished tablet, ensuring compliance and patient safety.
Patents and chemical supply listings often specify appearance, grade, and use-case to eliminate confusion. For those involved in research, analytical reports record melting points, density, and spectra, cross-checking each parameter with the theoretical profile. My contacts in regulatory affairs have emphasized more than once: omitting a detail at this stage cascades into downstream errors, sometimes impacting studies or regulatory audits. Only by recognizing the importance of every property—physical, chemical, and logistical—can supply chains deliver on patient needs, maintain trust, and secure the future of innovative antifungal treatments.
